300791 仙乐健康
2025/09 - 九个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入3,291,1747.96%4,211,0643,582,0222,507,2622,368,948
减:营业总成本3,046,4398.27%3,893,4663,311,5732,262,8722,111,162
    其中:营业成本2,229,3866.31%2,886,1152,497,9121,725,5571,593,733
               财务费用71,0937.62%79,56852,3137,17026,349
               资产减值损失(9,216)312.81%(5,105)405(4,977)(2,056)
公允价值变动收益1,362-68.24%(21,949)(57,672)(1,638)(1,046)
投资收益(2,178)-41.93%(4,773)2,22023,39525,190
    其中:对联营企业和合营企业的投资收益------------
营业利润260,7995.62%327,007282,025265,056289,815
利润总额254,9565.38%316,654273,257251,518280,901
减:所得税费用33,12313.34%34,63632,96939,23349,066
净利润221,8334.28%282,018240,288212,286231,834
减:非控股权益(38,434)41.95%(43,044)(40,751)----
股东净利润260,2678.53%325,062281,039212,286231,834

市场价值指针
每股收益 (元) *0.8527.82%1.3921.1991.1791.288
每股派息 (元) *----0.6501.1000.3500.400
每股净资产 (元) *7.980-15.39%9.76912.05313.85013.005
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容